Provided by Tiger Trade Technology Pte. Ltd.

Zentalis Pharmaceuticals, LLC

2.64
+0.08673.40%
Volume:201.42K
Turnover:528.50K
Market Cap:190.50M
PE:-1.27
High:2.67
Open:2.53
Low:2.49
Close:2.55
52wk High:3.95
52wk Low:1.01
Shares:72.25M
Float Shares:66.79M
Volume Ratio:0.61
T/O Rate:0.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0805
EPS(LYR):-2.3331
ROE:-49.18%
ROA:-24.51%
PB:0.75
PE(LYR):-1.13

Loading ...

May 16, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2022

Major Issues Report

8-K - Current report
Apr 11, 2022

Major Issues Report

8-K/A [Amend] - Current report
Apr 11, 2022

Major Issues Report

8-K - Current report
Apr 08, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 17, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]